# Sunshine Biopharma Inc.: Form 8-K, filed Mar 1, 2024

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2024-03-01
- Accepted by EDGAR: Mar 1, 2024, 16:19 ET
- Period: 2024-02-28
- Accession: 0001683168-24-001253
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/sunshine_8k.htm

Filed Mar 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-001253. Last ingested by Listed: Nov 13, 2026, 16:19 ET. No prices; not investment advice.